Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1997 Apr;225(4):370–376. doi: 10.1097/00000658-199704000-00005

Routine contralateral breast biopsy: helpful or irrelevant? Experience in 871 patients, 1979-1993.

H S Cody 3rd 1
PMCID: PMC1190744  PMID: 9114795

Abstract

OBJECTIVE: Is routine contralateral biopsy in the breast cancer patient justified, and by which parameters can the result be predicted in advance? SUMMARY BACKGROUND DATA: Routine contralateral biopsy remains controversial, and with the possible exception of an invasive lobular primary, little used by most surgeons. Previous series are biased by small sample size, by interpreting lobular carcinoma in situ (LCIS) as a positive result, by selection on the basis of tumor type, and by the inclusion of patients with clinical or mammographic abnormalities. METHODS: Among 1113 consecutive patients with breast cancer treated in the author's practice between 1979 and 1993 (excluding 77 patients who had a previous mastectomy, 131 who declined biopsy, and 34 with suspicious clinical or mammographic findings), 871 had a routine contralateral biopsy. RESULTS: Invasive cancers were found in 1.6%, duct carcinoma in situ in 1.4%, LCIS in 3.2%, and atypical hyperplasia in 6.9% of all random biopsies. If LCIS was excluded as a positive result, invasive lobular carcinoma was not significantly more bilateral than invasive duct (5.2% vs. 2.9%, p = 0.32), nor were in situ tumors more bilateral than invasive (2.5% vs. 3.0%, p = 0.76). Tumor size, axillary node status, and young age were not predictive of a positive result. A positive biopsy result was significantly more frequent in patients older than 50 years of age (4% vs. 1%, p = 0.016), and with a first-degree family history of breast cancer (6.3% vs. 2.2%, p = 0.004). CONCLUSIONS: The following conclusions can be made: 1. If LCIS was excluded as a positive biopsy result, invasive lobular was not significantly more bilateral than invasive duct cancer. 2. Family history and older age significantly predicted a positive biopsy, whereas young age, tumor size, and axillary node status did not. 3. Routine contralateral biopsy identified conditions (invasive cancer or duct carcinoma in situ) requiring immediate further management in 3.0% of patients, and markers of risk (LCIS or atypia) with the potential to influence future decisions in another 10.1%. 4. As a screening device applied in a high-risk population, with low cost and little morbidity, contralateral biopsy deserves wider consideration in an era of ever-earlier breast cancer diagnosis.

Full text

PDF
370

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adami H. O., Bergström R., Hansen J. Age at first primary as a determinant of the incidence of bilateral breast cancer. Cumulative and relative risks in a population-based case-control study. Cancer. 1985 Feb 1;55(3):643–647. doi: 10.1002/1097-0142(19850201)55:3<643::aid-cncr2820550328>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  2. Andersen L. I., Muchardt O. Simultaneous bilateral cancer of the brease--evaluation of the use of a contralateral biopsy. Acta Chir Scand. 1980;146(6):407–409. [PubMed] [Google Scholar]
  3. Anderson D. E. Some characteristics of familial breast cancer. Cancer. 1971 Dec;28(6):1500–1504. doi: 10.1002/1097-0142(197112)28:6<1500::aid-cncr2820280623>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  4. Ashikari R., Huvos A. G., Urban J. A., Robbins G. F. Infiltrating lobular carcinoma of the breast. Cancer. 1973 Jan;31(1):110–116. doi: 10.1002/1097-0142(197301)31:1<110::aid-cncr2820310115>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  5. Bernstein J. L., Thompson W. D., Risch N., Holford T. R. The genetic epidemiology of second primary breast cancer. Am J Epidemiol. 1992 Oct 15;136(8):937–948. doi: 10.1093/oxfordjournals.aje.a116566. [DOI] [PubMed] [Google Scholar]
  6. Chaudary M. A., Millis R. R., Bulbrook R. D., Hayward J. L. Family history and bilateral primary breast cancer. Breast Cancer Res Treat. 1985;5(2):201–205. doi: 10.1007/BF01805995. [DOI] [PubMed] [Google Scholar]
  7. Chaudary M. A., Millis R. R., Hoskins E. O., Halder M., Bulbrook R. D., Cuzick J., Hayward J. L. Bilateral primary breast cancer: a prospective study of disease incidence. Br J Surg. 1984 Sep;71(9):711–714. doi: 10.1002/bjs.1800710924. [DOI] [PubMed] [Google Scholar]
  8. Cody H. S., 3rd The impact of mammography in 1096 consecutive patients with breast cancer, 1979-1993: equal value for patients younger and older than age 50 years. Cancer. 1995 Nov 1;76(9):1579–1584. doi: 10.1002/1097-0142(19951101)76:9<1579::aid-cncr2820760913>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  9. Fenig J., Arlen M., Livingston S. F., Levowitz B. S. The potential for carcinoma existing synchronously on a microscopic level within the second breast. Surg Gynecol Obstet. 1975 Sep;141(3):394–396. [PubMed] [Google Scholar]
  10. Fisher E. R., Fisher B., Sass R., Wickerham L. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4). XI. Bilateral breast cancer. Cancer. 1984 Dec 15;54(12):3002–3011. doi: 10.1002/1097-0142(19841215)54:12<3002::aid-cncr2820541231>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  11. Foote F. W., Stewart F. W. Comparative Studies of Cancerous Versus Noncancerous Breasts. Ann Surg. 1945 Feb;121(2):197–222. doi: 10.1097/00000658-194502000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ford D., Easton D. F., Bishop D. T., Narod S. A., Goldgar D. E. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet. 1994 Mar 19;343(8899):692–695. doi: 10.1016/s0140-6736(94)91578-4. [DOI] [PubMed] [Google Scholar]
  13. Hancock S. L., Tucker M. A., Hoppe R. T. Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst. 1993 Jan 6;85(1):25–31. doi: 10.1093/jnci/85.1.25. [DOI] [PubMed] [Google Scholar]
  14. Hankey B. F., Curtis R. E., Naughton M. D., Boice J. D., Jr, Flannery J. T. A retrospective cohort analysis of second breast cancer risk for primary breast cancer patients with an assessment of the effect of radiation therapy. J Natl Cancer Inst. 1983 May;70(5):797–804. [PubMed] [Google Scholar]
  15. Hislop T. G., Elwood J. M., Coldman A. J., Spinelli J. J., Worth A. J., Ellison L. G. Second primary cancers of the breast: incidence and risk factors. Br J Cancer. 1984 Jan;49(1):79–85. doi: 10.1038/bjc.1984.12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. King R. E., Terz J. J., Lawrence W., Jr Experience with opposite breast biopsy in patients with operable breast cancer. Cancer. 1976 Jan;37(1):43–45. doi: 10.1002/1097-0142(197601)37:1<43::aid-cncr2820370107>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  17. Leis H. P., Jr Bilateral breast cancer. Surg Clin North Am. 1978 Aug;58(4):833–841. doi: 10.1016/s0039-6109(16)41595-1. [DOI] [PubMed] [Google Scholar]
  18. Lesser M. L., Rosen P. P., Kinne D. W. Multicentricity and bilaterality in invasive breast carcinoma. Surgery. 1982 Feb;91(2):234–240. [PubMed] [Google Scholar]
  19. Martin J. K., Jr, van Heerden J. A., Gaffey T. A. Synchronous and metachronous carcinoma of the breast. Surgery. 1982 Jan;91(1):12–16. [PubMed] [Google Scholar]
  20. Pressman P. I. Selective biopsy of the opposite breast. Cancer. 1986 Feb 1;57(3):577–580. doi: 10.1002/1097-0142(19860201)57:3<577::aid-cncr2820570330>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  21. Prior P., Waterhouse J. A. Incidence of bilateral tumours in a population-based series of breast-cancer patients. I. Two approaches to an epidemiological analysis. Br J Cancer. 1978 Apr;37(4):620–634. doi: 10.1038/bjc.1978.92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. ROBBINS G. F., BERG J. W. BILATERAL PRIMARY BREAST CANCER; A PROSPECTIVE CLINICOPATHOLOGICAL STUDY. Cancer. 1964 Dec;17:1501–1527. doi: 10.1002/1097-0142(196412)17:12<1501::aid-cncr2820171202>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  23. Rosen P. P., Groshen S., Kinne D. W., Hellman S. Contralateral breast carcinoma: an assessment of risk and prognosis in stage I (T1N0M0) and stage II (T1N1M0) patients with 20-year follow-up. Surgery. 1989 Nov;106(5):904–910. [PubMed] [Google Scholar]
  24. Rosen P. P., Groshen S., Kinne D. W. Prognosis in T2N0M0 stage I breast carcinoma: a 20-year follow-up study. J Clin Oncol. 1991 Sep;9(9):1650–1661. doi: 10.1200/JCO.1991.9.9.1650. [DOI] [PubMed] [Google Scholar]
  25. Smart C. R. Highlights of the evidence of benefit for women aged 40-49 years from the 14-year follow-up of the Breast Cancer Detection Demonstration Project. Cancer. 1994 Jul 1;74(1 Suppl):296–300. doi: 10.1002/cncr.2820741314. [DOI] [PubMed] [Google Scholar]
  26. Smith B. L., Bertagnolli M., Klein B. B., Batter S., Chang M., Douville L. M., Eberlein T. J. Evaluation of the contralateral breast. The role of biopsy at the time of treatment of primary breast cancer. Ann Surg. 1992 Jul;216(1):17–21. doi: 10.1097/00000658-199207000-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Storm H. H., Jensen O. M. Risk of contralateral breast cancer in Denmark 1943-80. Br J Cancer. 1986 Sep;54(3):483–492. doi: 10.1038/bjc.1986.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Tulusan A. H., Ronay G., Egger H., Willgeroth F. A contribution to the natural history of breast cancer. V. Bilateral primary breast cancer: incidence, risks and diagnosis of simultaneous primary cancer in the opposite breast. Arch Gynecol. 1985;237(2):85–91. doi: 10.1007/BF02199712. [DOI] [PubMed] [Google Scholar]
  29. Urban J. A., Papachristou D., Taylor J. Bilateral breast cancer: biopsy of the opposite breast. Cancer. 1977 Oct;40(4 Suppl):1968–1973. doi: 10.1002/1097-0142(197710)40:4+<1968::aid-cncr2820400832>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  30. Wanebo H. J., Senofsky G. M., Fechner R. E., Kaiser D., Lynn S., Paradies J. Bilateral breast cancer. Risk reduction by contralateral biopsy. Ann Surg. 1985 Jun;201(6):667–677. doi: 10.1097/00000658-198506000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Yahalom J., Petrek J. A., Biddinger P. W., Kessler S., Dershaw D. D., McCormick B., Osborne M. P., Kinne D. A., Rosen P. P. Breast cancer in patients irradiated for Hodgkin's disease: a clinical and pathologic analysis of 45 events in 37 patients. J Clin Oncol. 1992 Nov;10(11):1674–1681. doi: 10.1200/JCO.1992.10.11.1674. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES